Executive Management

Graham Mullis
Chief Executive Officer

  • Appointed CEO of Novacyt in 2014
  • Over 30 years in healthcare; pharmaceuticals & medical device markets
  • Internationally experienced leader with multi-disciplinary background
  • Led multiple successful exits; Biocompatibles Eyecare, ClearLab, VisionTec and Optivue
  • C-level executive with FTSE 250 (Biocompatibles International) and NASDAQ (1-800 CONTACTS)

Anthony Dyer
Chief Financial Officer

  • Joined Group in 2010
  • 18 years in healthcare; pharmaceuticals & medical devices
  • Growth business and M&A experience, including RiboTargets / British Biotech and BioFocus / Galapagos
  • FCCA qualified 20 years; commercial and audit background

Mandy Cowling
Corporate & Investor Relations Manager

  • Mandy joined Novacyt in June 2012.
  • 17 years experience of working in multifaceted roles that encompass company secretarial, investor relations management and personal assistant duties, supporting company Directors and Senior Management.

Lisa Henriet
Group Operations Director

  • Joined Novacyt in May 2016
  • Over 25 years experience gained in a varied range of sectors at Senior and Executive Management lever within SME companies
  • Multifaceted roles encompassing finance, IT, Procurement, HR, Manufacturing, Logistics and Facilities Management
  • An improvement and change management professional

Wendy Karban 
Group HR Manager

  • Joined Novacyt February 2017
  • Over 25 years HR experience gained in a diverse range of sectors
  • Chartered member of the CIPD
  • Post Graduate Certificate in Employment Law

Steve Gibson
Group Financial Controller

  • Joined Novacyt in April 2017
  • Over 12 years’ experience working at an internationally recognized blue-chip company
  • Trusted finance business partner for multi-billion dollar deals
  • CIMA qualified 10 years; commercial and financial management background
  • Lived & worked in the UAE

Phil Sefton
Group Commercial Director

  • Joined April 2017
  • Over 30 years experience in life sciences, molecular diagnostic and classical diagnostic markets.
  • Commercial leadership posts in QIAGEN, TAP Biosystems, LGC Genomics and Boehringer Mannheim
  • Global experience of building successful businesses

Paul Eros
Corporate Business Development Director

  • Joined Novacyt 1st November 2017
  • Over 30 years experience in molecular diagnostics, classical IVD markets and life science research with Becton Dickinson, Roche and DiaSorin
  • Globally experienced marketer and commercial leader

Navin Nauth-Misir
RA & QA Director

  • Joined Novacyt in May 2019
  • Over 30 years experience with medical devices and In Vitro Diagnostic medical devices
  • Experience in the NHS, regulatory authority and manufacturing companies
  • Extensive involvement in standards development and expert working groups
  • International regulatory expertise